Origen de la red de primer grado Frank W. Falkenberg.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
CyTuVax BV
 CyTuVax BV Pharmaceuticals: MajorHealth Technology CyTuVax BV develops vaccinations for cancer treatment. Its vaccination technology includes an adjuvant composed of depot-bound cytokines acting as immune response modifiers. The firm also provides adjuvant technology licensing services. The company was founded by René Vleugels and Frank W. Falkenberg in 2011 and is headquartered in Maastricht, the Netherlands.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Frank W. Falkenberg a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Maastricht University | College/University | Corporate Officer/Principal | |
| Radboud University Nijmegen | College/University | Doctorate Degree | |
| NovoVacs BV | Founder | ||
AdjuTec BV
 AdjuTec BV Pharmaceuticals: MajorHealth Technology AdjuTec BV is a Dutch company that manufactures personalized therapeutic tumor vaccines for pancreatic and liver cancer patients. The company is based in Maastricht, Netherlands. The company was founded in 2017 by René Vleugels. | Pharmaceuticals: Major | Founder |
Estadísticas
Internacional
| Países Bajos | 6 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
Operativa
| Founder | 4 |
| President | 1 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| René Vleugels | 6 |
- Bolsa de valores
- Insiders
- Frank W. Falkenberg
- Conexiones Empresas
